Page last updated: 2024-10-26

dipyridamole and Common Migraine

dipyridamole has been researched along with Common Migraine in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kruuse, C1
Lassen, LH1
Iversen, HK1
Oestergaard, S1
Olesen, J1

Trials

1 trial available for dipyridamole and Common Migraine

ArticleYear
Dipyridamole may induce migraine in patients with migraine without aura.
    Cephalalgia : an international journal of headache, 2006, Volume: 26, Issue:8

    Topics: Administration, Oral; Adult; Dipyridamole; Female; Headache Disorders, Secondary; Humans; Male; Midd

2006